Mr Abram Ellis > Simpson Thacher & Bartlett LLP > Washington DC, United States > Lawyer Profile

Simpson Thacher & Bartlett LLP Offices

Simpson Thacher & Bartlett LLP
115 F STREET, N.W
WASHINGTON D.C. 20004
DISTRICT OF COLUMBIA
United States
Visit website 1 202 636 5500 1 202 636 5502

Mr Abram Ellis

Abram Ellis photo
+1-202-636-5579 aellis@stblaw.com

Work Department

Litigation/Antitrust and Trade Regulation

Position

Recognized as a “Rising Star” and “Next Generation Lawyer” in antitrust litigation, Abram Ellis is a Partner in the Firm’s Washington, D.C. office. His practice comprises all aspects of competition law, from defending clients against complex class action antitrust litigation to helping clients obtain regulatory clearance from domestic and international competition authorities for significant transactions. An integral member of the “Antitrust Team of the Year” (Chambers USA 2016), Abram is particularly experienced in antitrust litigation involving complex financial instruments, the healthcare industry and employment issues. In addition to his robust antitrust practice, Abram advises leading private equity funds, financial institutions and major corporations on regulatory and compliance matters relating to cross-border activities, including with respect to OFAC, FCPA and export matters. Recent representations include: representing Change Healthcare in the DOJ’s challenge of UnitedHealthGroup’s proposed acquisition of Change Healthcare; the OWGR in ongoing litigation involving LIV; HCA in the FTC’s proposed review of the sale of certain hospitals in Louisiana by HCA; HCA in pending antitrust litigation in North Carolina state and federal court alleging HCA engaged in monopolistic conduct in violation of state and federal antitrust laws; Covestro in antitrust class actions involving MDI and TDI; Tyson Foods in a wage fixing antitrust class action alleging a decades-long conspiracy to fix wages; McKesson in dismissal of antitrust class action concerning alleged price-fixing conspiracy among manufacturers of generic pharmaceuticals; Micron in dismissal of a proposed antitrust class action alleging a conspiracy involving DRAM; HCA in the FTC’s challenge of HCA’s proposed acquisition of certain hospital assets from Steward Healthcare; and JPMorgan in antitrust and CEA class actions concerning the alleged manipulation of LIBOR; ISDA in antitrust class actions and government investigations concerning credit default swaps.

Education

University of Michigan Law School (J.D., cum laude, 2005); Johns Hopkins School of Advanced International Studies (M.A., 2002), John C. Foster Award, SAIS Review Book Review Editor; Brigham Young University (B.A., 2000).

Lawyer Rankings

United States > Antitrust > Civil litigation/class actions: defense

(Next Generation Partners)

Abram Ellis – Simpson Thacher & Bartlett LLP

Simpson Thacher & Bartlett LLP is known for advising and representing both plaintiffs and defendants in antitrust litigation concerning monopolization, price fixing and tying claims across major industries such as chemicals, insurance, pharma, agricultural products, finance, and telecoms. The team is led by antitrust co-chair Sara Razi who has extensive private-sector and government antitrust experience, fellow co-chair John Terzaken, a leading antitrust litigator with a broad antitrust practice including investigations and follow-on litigation and litigation co-chair Jonathan Youngwood in New York, who co-chairs the litigation department. Other heads of team include New York-based antitrust co-chair Peter Guryan and litigation co-chair Lynn Neuner. Abram Ellis is highly regarded in the market and is especially experienced in antitrust litigation involving financial instruments, the healthcare industry and employment matters. All attorneys are based in Washington DC unless otherwise specified.

United States > Antitrust > Cartel

(Next Generation Partners)

Abram Ellis

–

Simpson Thacher & Bartlett LLP

Simpson Thacher & Bartlett LLP‘s highly active practice represents clients on multiple major new and ongoing cartel matters, leveraging the deep in-house experience of the team to represent clients in international and domestic investigations and subsequent litigation. Internal investigations, leniency applications, and multijurisdictional compliance programs are particular strengths of the group. The practice is jointly overseen by Washington DC-based John Terzaken, DC’s Sara Razi, as well as Peter Guryan in the New York office. Terzaken, the former director of criminal enforcement at the DOJ’s Antitrust Division and a leading name in the field, concentrates on market sector investigations and litigations across all major industries with an emphasis on financial services and fintech. Razi is a former senior official at the FTC, while Guryan formerly served as a trial attorney in the Antitrust Division. Jeffrey Knox, also based in DC, advises multinational corporations and independent board committees in high-stakes investigations by the DOJ, SEC, CFTC, and other federal and state enforcement regulators. Another key DC name is Abram Ellis, who regularly acts on follow-on cartel litigation.

Lawyer Rankings

Top Tier Firm Rankings

Firm Rankings